A carregar...
NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer
BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) is an aggressive form of breast cancer and is historically associated with poor outcomes compared with HER2-negative MBC. Since 1998, four drugs have been globally approved for the targeted treatment...
Na minha lista:
| Publicado no: | Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591587/ https://ncbi.nlm.nih.gov/pubmed/26428301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0118-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|